3 Result: Trevena
Pre-Market Movers: Marker Therapeutics Surges on MT-601 Potential, Trevena on Milestone Payment
May 31st, 2023
Marker Therapeutics, Inc. (Nasdaq: MRKR) shared positive pre-clinical data regarding their T cell product candidate, MT-601, which targets multiple tumor-associated antigens (multiTAA) in lymphoma cells, including those resistant to CD19 CAR T cell t. Read more
FREYR Battery and Trevena Surpass Estimates, SoFi Technologies Downgraded, PlayAGS Upgraded
May 15th, 2023
FREYR Battery (NYSE: FREY) has announced its first quarter 2023 financial results, reporting a loss of $0.09 per share. This result surpasses the consensus estimate of a loss of $0.29 per share. Despite the loss, the company's pre-market trading refl. Read more
Trevena and Immuron Make Strides in Medical Advancements with New Approvals and Collaborations, Imperial Petroleum Posts Record Revenues and Profitability, Resulting in a Surge in Stock Prices
May 08th, 2023
Trevena, Inc. (Nasdaq: TRVN) made a significant announcement that its partner in China, Jiangsu Nhwa, has received formal approval from the National Medical Products Administration for OLINVYK, a medication for adults who require intravenous opioid a. Read more
Want To Find Some News?
News By Industries
Recent Post
-
NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025Earnings Preview: Amicus Therapeutics, ANSYS, and Etsy Take Center Stage
February 16th, 2025Key Metrics: Walmart, Booking Holdings, and Insmed Earnings Due
February 16th, 2025
Member Login